Invention Grant
- Patent Title: Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
- Patent Title (中): 包含水溶性治疗剂和释放改良剂的缓释药物递送系统
-
Application No.: US13924776Application Date: 2013-06-24
-
Publication No.: US08834884B2Publication Date: 2014-09-16
- Inventor: John T. Trogden , Robert T. Lyons
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Jennifer C. Cheng
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K39/395 ; A61K48/00 ; A61K9/16 ; A61K47/10 ; A61K31/711 ; A61K9/19
Abstract:
A biocompatible, sustained release intraocular drug delivery system comprising a protein or polynucleotide therapeutic agent, a polymeric carrier for the therapeutic agent and a long chain fatty alcohol release modifier. The biocompatible, sustained release intraocular drug delivery system can be used to treat an ocular condition.
Public/Granted literature
Information query
